Cargando…

Axitinib induces senescence-associated cell death and necrosis in glioma cell lines: The proteasome inhibitor, bortezomib, potentiates axitinib-induced cytotoxicity in a p21(Waf/Cip1) dependent manner

Glioblastoma is associated with a poor overall survival despite new treatment advances. Antiangiogenic strategies targeting VEGF based on tyrosine kinase inhibitors (TKIs) are currently undergoing extensive research for the treatment of glioma. Herein we demonstrated that the TKI axitinib induces DN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morelli, Maria Beatrice, Amantini, Consuelo, Nabissi, Massimo, Cardinali, Claudio, Santoni, Matteo, Bernardini, Giovanni, Santoni, Angela, Santoni, Giorgio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356889/ https://www.ncbi.nlm.nih.gov/pubmed/27926485 http://dx.doi.org/10.18632/oncotarget.13769

Ejemplares similares

Axitinib induces DNA damage response leading to senescence, mitotic catastrophe, and increased NK cell recognition in human renal carcinoma cells
por: Morelli, Maria Beatrice, et al.
Publicado: (2015)

Capsaicin triggers autophagic cell survival which drives epithelial mesenchymal transition and chemoresistance in bladder cancer cells in an Hedgehog-dependent manner
por: Amantini, Consuelo, et al.
Publicado: (2016)

Post-transcriptional regulation of 5'-untranslated regions of human Transient Receptor Potential Vanilloid type-1 (TRPV-1) channels: role in the survival of glioma patients
por: Nabissi, Massimo, et al.
Publicado: (2016)

Danger- and pathogen-associated molecular patterns recognition by pattern-recognition receptors and ion channels of the transient receptor potential family triggers the inflammasome activation in immune cells and sensory neurons
por: Santoni, Giorgio, et al.
Publicado: (2015)

The TRPV1 ion channel regulates thymocyte differentiation by modulating autophagy and proteasome activity
por: Amantini, Consuelo, et al.
Publicado: (2017)

Functional In Vitro Assessment of VEGFA/NOTCH2 Signaling Pathway and pRB Proteasomal Degradation and the Clinical Relevance of Mucolipin TRPML2 Overexpression in Glioblastoma Patients
por: Santoni, Giorgio, et al.
Publicado: (2022)

Involvement of the TRPML Mucolipin Channels in Viral Infections and Anti-viral Innate Immune Responses
por: Santoni, Giorgio, et al.
Publicado: (2020)

The Mucolipin TRPML2 Channel Enhances the Sensitivity of Multiple Myeloma Cell Lines to Ibrutinib and/or Bortezomib Treatment
por: Santoni, Giorgio, et al.
Publicado: (2022)

“Immuno-Transient Receptor Potential Ion Channels”: The Role in Monocyte- and Macrophage-Mediated Inflammatory Responses
por: Santoni, Giorgio, et al.
Publicado: (2018)

Pathophysiological Role of Transient Receptor Potential Mucolipin Channel 1 in Calcium-Mediated Stress-Induced Neurodegenerative Diseases
por: Santoni, Giorgio, et al.
Publicado: (2020)

Sorafenib induces cathepsin B-mediated apoptosis of bladder cancer cells by regulating the Akt/PTEN pathway. The Akt inhibitor, perifosine, enhances the sorafenib-induced cytotoxicity against bladder cancer cells
por: Amantini, Consuelo, et al.
Publicado: (2015)

The role of transient receptor potential vanilloid type-2 ion channels in innate and adaptive immune responses
por: Santoni, Giorgio, et al.
Publicado: (2013)

Unveiling the Molecular Mechanisms Driving the Capsaicin-Induced Immunomodulatory Effects on PD-L1 Expression in Bladder and Renal Cancer Cell Lines
por: Morelli, Maria Beatrice, et al.
Publicado: (2022)

Coexpression of TRPML1 and TRPML2 Mucolipin Channels Affects the Survival of Glioblastoma Patients
por: Santoni, Giorgio, et al.
Publicado: (2022)

A Case Report with Severe Thrombocytopenia Induced by Axitinib
por: Koksal, Ulkuhan I., et al.
Publicado: (2020)

Beyond the Checkpoint: Severe Axitinib-induced Liver Injury
por: Yeo, Yee Hui, et al.
Publicado: (2023)

High CTLA-4 expression correlates with poor prognosis in thymoma patients
por: Santoni, Giorgio, et al.
Publicado: (2018)

Cannabinoids synergize with carfilzomib, reducing multiple myeloma cells viability and migration
por: Nabissi, Massimo, et al.
Publicado: (2016)

Transient Receptor Potential Mucolipin-1 Channels in Glioblastoma: Role in Patient’s Survival
por: Morelli, Maria Beatrice, et al.
Publicado: (2019)

Calcium influx, oxidative stress, and apoptosis induced by TRPV1 in chronic myeloid leukemia cells: Synergistic effects with imatinib
por: Maggi, Federica, et al.
Publicado: (2023)

ERK Phosphorylation Regulates the Aml1/Runx1 Splice Variants and the TRP Channels Expression during the Differentiation of Glioma Stem Cell Lines
por: Santoni, Giorgio, et al.
Publicado: (2021)

Overexpression of transient receptor potential mucolipin-2 ion channels in gliomas: role in tumor growth and progression
por: Morelli, Maria Beatrice, et al.
Publicado: (2016)

Selenium substituted axitinib reduces axitinib side effects and maintains its anti-renal tumor activity
por: Fu, Ying, et al.
Publicado: (2022)

Axitinib in Metastatic Renal Cell Carcinoma
por: Mittal, Kriti, et al.
Publicado: (2012)

Correction: Liberati, S., et al. Loss of TRPV2 Homeostatic Control of Cell Proliferation Drives Tumor Progression. Cells 2014, 3, 112–128
por: Liberati, Sonia, et al.
Publicado: (2014)

Loss of TRPV2 Homeostatic Control of Cell Proliferation Drives Tumor Progression
por: Liberati, Sonia, et al.
Publicado: (2014)

Exploring treatment with Ribociclib alone or in sequence/combination with Everolimus in ER(+)HER2(−)Rb wild-type and knock-down in breast cancer cell lines
por: Marinelli, Oliviero, et al.
Publicado: (2020)

Knock-Down of Mucolipin 1 Channel Promotes Tumor Progression and Invasion in Human Glioblastoma Cell Lines
por: Santoni, Giorgio, et al.
Publicado: (2021)

Management of axitinib (AG-013736)-induced fatigue and thyroid dysfunction, and predictive biomarkers of axitinib exposure: results from phase I studies in Japanese patients
por: Fujiwara, Yutaka, et al.
Publicado: (2011)

ATLAS trial of adjuvant axitinib in patients with renal cell carcinoma: subgroup analyses with focus on axitinib dosing and racial groups
por: Quinn, D.I., et al.
Publicado: (2021)

Effect of ketoconazole on the pharmacokinetics of axitinib in healthy volunteers
por: Pithavala, Yazdi K., et al.
Publicado: (2010)

Axitinib for the Management of Metastatic Renal Cell Carcinoma
por: Escudier, Bernard, et al.
Publicado: (2012)

Axitinib: Newly Approved for Renal Cell Carcinoma
por: Tyler, Timothy
Publicado: (2012)

Design, Synthesis, and Biological Evaluation of Axitinib Derivatives
por: Wei, Na, et al.
Publicado: (2018)

Inhibition of Axitinib on Buspirone Metabolism in vitro and in vivo
por: Zhang, Bo-Wen, et al.
Publicado: (2022)

Mechanosensation and Mechanotransduction in Natural Killer Cells
por: Santoni, Giorgio, et al.
Publicado: (2021)

TRPML2 Mucolipin Channels Drive the Response of Glioma Stem Cells to Temozolomide and Affect the Overall Survival in Glioblastoma Patients
por: Morelli, Maria Beatrice, et al.
Publicado: (2022)

Transient Receptor Potential (TRP) Channels in Haematological Malignancies: An Update
por: Maggi, Federica, et al.
Publicado: (2021)

Glioblastoma Cells Do Not Affect Axitinib-Dependent Senescence of HUVECs in a Transwell Coculture Model
por: Merolle, Matilde, et al.
Publicado: (2020)

Axitinib Induces and Aggravates Hypertension Regardless of Prior Treatment With Tyrosine Kinase Inhibitors
por: Kadowaki, Hiroshi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9adqkjstsbdou57ljnu706a4u5